Responses
Systemic lupus erythematosus
Risk of flare and damage accrual after tapering glucocorticoids in modified serologically active clinically quiescent patients with systemic lupus erythematosus: a multinational observational cohort study
Compose a Response to This Article
Other responses
No responses have been published for this article.